ShengJing Hospital of China Medical University (China Medical University No.2 Ho spital )
π¨π³China
Clinical Trials
113
Active:6
Completed:26
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:4
Phase 2:16
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (67 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
34 (50.7%)Phase 2
16 (23.9%)Phase 4
9 (13.4%)Phase 1
4 (6.0%)Phase 3
3 (4.5%)Early Phase 1
1 (1.5%)Interventional AI-Human Collaboration for Liver Tumor Diagnosis
Not Applicable
Recruiting
- Conditions
- Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Hepatic MetastasisHepatic HemangiomaCystFocal Nodular Hyperplasia
- First Posted Date
- 2025-09-04
- Last Posted Date
- 2025-09-22
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT07153783
- Locations
- π¨π³
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
Near-Infrared Imaging of Motor Imagery Effects in Spinal Cord Injury
Not Applicable
Recruiting
- Conditions
- SCI - Spinal Cord InjuryMotor ImageryBrain-Computer Interfaces
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT07106060
- Locations
- π¨π³
Rehabilitation Center of Shengjing Hospital, China Medical University, Shenyang, Liaoning, China
A Randomized Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC).
Not Applicable
Not yet recruiting
- Conditions
- TNBC - Triple-Negative Breast Cancer
- Interventions
- Drug: JS004 in combination with toripalimab and chemotherapyDrug: Toripalimab and chemotherapyDrug: Chemotherapy
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 125
- Registration Number
- NCT07101614
Effect of Threshold Pressure-Loaded RMT + tTBS on Respiratory Function in SCI Patients
Not Applicable
Recruiting
- Conditions
- Spinal Cord Injuries
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT07050069
- Locations
- π¨π³
Rehabilitation Center of Shengjing Hospital, China Medical University, Shenyang, Liaoning, China
Study on Dynamic Changes of Serum IGF-1 Post-Cerebral Hemorrhage and Its Prognostic Correlation
Not yet recruiting
- Conditions
- Insulin-Like Growth Factor I
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT07043504
- Prev
- 1
- 2
- 3
- 4
- 5
- 23
- Next
News
No news found